Menu
Back to Journals » Drug Design, Development and Therapy » Volume 11
Review
Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 15,417 | Dovepress* | 13,071+ | 1,672 | 14,743 | |
| PubMed Central* | 2,346 | 471 | 2,817 | ||
| Totals | 15,417 | 2,143 | 17,560 | ||
| *Since 21 March 2017 | |||||
View citations on PubMed Central and Google Scholar